“immunotherapy” Archives

in
Entry Author Date Location
Kite Unveils Anticipated CAR-T Cancer Data: Positive But Not Complete 09/26/16 National
Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap 09/09/16 National
Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches 09/07/16 National
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 07/12/16 Boston
Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact 06/29/16 Boston
Federal Oversight Group Has Complaints But Says Yes To CRISPR Trial 06/21/16 National
Sean Parker To Fund CRISPR Trial, And Other Gene Edit Milestones 06/20/16 National
Alpine Immune Sciences, Former Dendreon CEO’s Latest Startup, Gets $48M 06/13/16 Seattle
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
Agios, Celgene Jump into Immuno-Oncology in Revamped Alliance 05/17/16 Boston
With CRISPR in Humans On The Horizon, Will the Public Back Intellia? 04/29/16 Boston
Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy 03/15/16 Boston
West Coast Bio Roundup: UCLA Cashes In, BioMarin Tries Again & More 03/04/16 San Francisco
JLabs @ TMC Opens Houston Campus, Home to 21 Biotech Startups 03/02/16 Texas
Soon-Shiong Makes Case for “Cancer MoonShot” at Biocom Conference 02/26/16 San Diego
CRISPR: The Path to Clinical Trials 01/29/16 Boston
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells 01/27/16 San Francisco
Ex-Biogen Exec’s New Startup Gets $61M More For Exosome Drugs 01/26/16 Boston
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy 12/07/15 Boston
What Three Biotechs Could Tell Us About The Pfizer-Allergan Merger 12/01/15 National
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
Page 1 of 4 next page »